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The zinc finger protein ZNF804A rs1344706 variant is a replicated genome-wide significant risk
variant for schizophrenia and bipolar disorder. While its association with altered brain structure
and cognition in patients and healthy risk allele carriers is well documented, the characteristics and
function of the gene in the brain remains poorly understood. Here, we used in situ hybridization to
determine mRNA expression levels of the ZNF804A rodent homologue, Zfp804a, across multiple
postnatal neurodevelopmental timepoints in the rat brain. We found changes in Zfp804a
expression in the rat hippocampus, frontal cortex, and thalamus across postnatal
neurodevelopment. Zfp804a mRNA peaked at postnatal day (P) 21 in hippocampal CA1 and DG
regions, and was highest in the lower cortical layers of frontal cortex at P1, possibly highlighting a
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role in developmental migration. Using immunofluorescence, we found that ZFP804A colocalized with neurons and not astrocytes. In primary cultured cortical neurons, we found that
Zfp804a expression was significantly increased when neurons were exposed to glutamate [20 μM],
but this increase was blocked by the N-methyl-D-aspartate receptor (NMDAR) antagonist
MK-801. Expression of Comt, Pde4b, and Drd2, genes previously shown to be regulated by
ZNF804A overexpression, were also significantly changed in an NMDA-dependent manner. Our
results describe, for the first time, the unique postnatal neurodevelopmental expression of Zfp804a
in the rodent brain and demonstrate that glutamate potentially plays an important role in the
regulation of this psychiatric susceptibility gene. These are critical steps towards understanding
the biological function of ZNF804A in the mammalian brain.
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1. Introduction
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The gene that encodes ZNF804A is a widely studied susceptibility gene for schizophrenia
and bipolar disorder. It was the first gene to reach genome-wide significance for psychosis
(O'Donovan et al., 2008) and its association with both schizophrenia and bipolar disorder
has been subsequently confirmed in multiple genome-wide association studies (GWASs;
Riley et al., 2010; Williams et al., 2011; Zhang et al., 2011). Studies of the single nucleotide
polymorphism (SNP) rs1344706 in both psychiatric patients and healthy risk allele carriers
have demonstrated effects on white and gray matter volume, white matter tract integrity,
functional connectivity (Esslinger et al., 2009; Ikuta et al., 2014; Lencz et al., 2010;
Voineskos et al., 2011; Wei et al., 2015), and cognition (Chen et al., 2012; Esslinger et al.,
2011; Hashimoto et al., 2010; Walter et al., 2011; Walters et al., 2010), indicating potential
functional consequences of this gene variant.

Author Manuscript

While these findings illustrate the potential wide-ranging effects of a ZNF804A
polymorphism, little is known about the biological functions of the gene itself. ZNF804A is
expressed in the brain and is predicted to encode a protein with a C2H2 zinc finger domain,
which suggests a role in DNA or RNA binding (Donohoe et al., 2010). In human post
mortem dorsolateral prefrontal cortical tissue, ZNF804A expression is highest fetally, with
levels decreasing at a rate of 11% per year on average during infancy and childhood (Tao et
al., 2014). These studies provide evidence that ZNF804A has a role in gene regulatory and
neurodevelopmental processes, and given the putative gene regulation role of ZNF804A in
human neurons (Bernstein et al., 2014), it is critical to know the location and timing of gene
expression within the mammalian brain. Moreover, because disorders such as schizophrenia
are neurodevelopmental in nature, details about the temporal and spatial changes in
ZNF804A transcript levels are especially pertinent. Current knowledge on ZNF804A
expression in neurodevelopment is restricted to just a few regions of the brain. Therefore,
we performed in situ hybridization on both coronal and sagittal sections from throughout the
rat brain at multiple postnatal time points to determine a comprehensive postnatal brain
expression profile of the ZNF804A rodent homologue, Zfp804a.
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Glutamatergic neurotransmitter activity is an important molecular component of healthy
neurodevelopmental processes and there is considerable evidence to suggest that there is
glutamatergic neuronal dysfunction in schizophrenia pathophysiology (Javitt, 2012; Olney et
al., 1999). In particular, NMDAR hypofunction appears to be an important feature of the
disorder, leading to possible secondary effects on dopaminergic systems (Javitt, 2007). We
therefore used quantitative polymerase chain reaction (qPCR) to investigate expression
levels of Zfp804a in primary cultured cortical neurons treated with glutamate, and also
treated with glutamate in the presence of MK-801. Additionally, we quantified the
expression levels of three other schizophrenia-relevant genes (Comt, Pde4b, and Drd2) in
the same primary cultured cortical neurons.

2. Methods
Author Manuscript

2.1 Animals
Subjects used for this study were male Long-Evans (Charles River Laboratories,
Wilmington, Massachusetts) rats from postnatal 1-86 days of age. Rats had ad libitum access
to food and water. All animal procedures were approved by the Feinstein Institute Medical
Research Institutional Animal Care and Use Committee and maintained according to
National Institutes of Health guidelines.
2.2 In situ hybridization

Author Manuscript

Rats were sacrificed by decapitation on postnatal day 1 (P1; n=6), P7 (n=6), P21 (n=5), P49
(n=5) or P86 (n=6). The rat pups within each postnatal day group all came from the same
litter. Whole brains were rapidly removed and frozen on dry ice. Sections (14 μm) were cut
at −20°C on a cryostat (Leica, Nussloch, Germany) and thaw-mounted onto poly-L-lysinecoated glass slides. Each slide had a section from P1, P7, P21, P49 and P86 with equivalent
regions of the brain to enable direct comparison. The sections were air-dried for at least 30
min, fixed in 4% paraformaldehyde in 0.1 M PBS for 5 min, rinsed in PBS for 1 min,
delipidated in 70% ethanol for 4 min, and stored in 95% ethanol at 4°C.

Author Manuscript

Hybridizations were performed as previously described (Hall et al., 2001). A cDNA
antisense probe (45mer) was synthesized commercially (MWG Operon, Huntsville, AL)
complementary to nucleotides 122-166 of Zfp804a mRNA (XM_008775447, 5’CCTTCAGATCCTCCAGAGCTTTGGCAATAGTGTTCTCCTTCTCAG - 3’). These
oligonucleotides were 3'- end-labeled with [β-S35] dATP (1200 Ci/mmol; Perkin ElmerNEN) in a 30:1 molar ratio of radiolabeled ATP:oligonucleotide using terminal
deoxynucleotidyl transferase. Specific activity of the [S35]-labeled probe was between 2.0
×105 and 3.0 × 105 dpm/μl probe. To define non-specific hybridization, adjacent slidemounted sections were incubated with radiolabeled oligonucleotide in the presence of an
excess (100X) concentration of unlabeled oligonucleotide probe. After hybridization,
sections were opposed to Kodak BioMax MR x-ray film for 1–2 weeks to obtain optimal
exposure. For silver grains, sections were dipped in K5 photographic emulsion (Ilford,
Cheshire, UK) and exposed for 10 weeks at 4°C before being developed and counterstained
with 0.01% thionin.
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Following development of the autoradiographic film, images were digitized, and gene
expression was measured by image densitometry. Optical density was determined using
ImageJ imaging software (http://rsbweb.nih.gov/ij/; Schneider et al., 2012). All densitometry
measures were corrected by subtracting the corresponding background measures for that
specific brain region. For silver grain analysis, images were captured using Leica QWIN
imaging software using a 63X objective under oil-immersion. Silver grain density was
assessed using a thresholded particle analysis in ImageJ. A specific grain count was then
calculated by subtracting total and nonspecific counts. One-way analysis of variance
(ANOVA) with Tukey's HSD post hoc tests were used to compare expression differences
between groups. Statistical significance was set at a level of P < 0.05.
2.3 Immunofluorescence

Author Manuscript
Author Manuscript

16 μM sections from frozen rat brains were fixed using 4% paraformaldehyde and rinsed
twice in 1X PBS followed by permeabilization in 1X PBST for 30 mins. Slides were then
transferred to a humidified chamber and blocked for 30 mins in 1XPBST/5% heat
inactivated donkey serum, followed by incubation in the appropriate primary antibody: goat
polyclonal anti-ZNF804A (S-16; Santa Cruz Biotechnology, Santa Cruz, CA) 1:50, rabbit
polyclonal anti-GFAP antibody (abcam, Cambridge, MA) 1:1000, rabbit polyclonal antiNeuN antibody (abcam) 1:500. Slides were incubated overnight at 4°C, washed 3 times in
PBST, then blocked in 1XPBST/ 5% heat inactivated donkey serum. Sections were then
incubated in secondary antibody and 1XPBST/ 5% heat inactivated donkey serum at 25°C
for 2 hours. Secondary antibodies were Alexa Fluor 488 (1:50) and Alexa Fluor 546 (1:500;
Molecular probes, Eugene, OR). Sections were then mounted in Vectashield HardSet
mounting medium with DAPI (Vector laboratories, Burlingame, CA). Images were acquired
on a Leica DMI 4000B inverted wide field fluorescence microscope at 20X. For negative
controls, sections were incubated in non-immune serum followed by secondary antibody to
check for non-specific binding.
2.4 Neuronal cortical cultures
Cortical neurons were dissected from embryonic day 19 rats and cultured in Neurobasal
medium containing 2% B27, 1mM sodium pyruvate, 100 units/ml penicillin, 100 μg/ml
streptomycin, and 2mM Glutamax for 10 days before being incubated for 3 hours in either
glutamate [20 μM] (Sigma-Aldrich, St Louis, MO), glutamate plus MK-801 [20 μM] (Tocris
Biosciences, Bristol, UK) in complete Neurobasal medium.
2.5 RNA isolation and quantitative PCR (qPCR)

Author Manuscript

mRNA was isolated from cultured cortical neurons using a RNeasy kit (Qiagen, Valencia,
California). Reverse transcription was performed using an iScript kit (BioRad, Hercules,
California, USA). qPCR was performed using SYBR green (BioRad), as previously
described (Zhong et al., 2007). Primers were as follows: Hprt1: Forward 5’TGTTTGTGTCATCAGCGAAAGTG -3’, Reverse: 5’-ATTCAACTTGCCGCTTTTTA-3’,
Zfp804a: Forward 5’-TCAAAGTGCTTCAGCCACAC-3’, Reverse: 5’ATGGGGTAAGGGTGGAAAAG-3’, Pde4b: Forward: 5’CAGCTCATGACCCAGATAAGTGG-3’, Reverse: 5’-
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GTCTGCACAATGTACCATGTTGCG-3’, Comt: Forward: 5’ATCTTCACGGGGTTTCAGTG-3’ Reverse: 5’-GAGCTGCTGGGGACAGTGAG-3’ and,
Drd2: Forward 5’-TGTCCTCCAGGCAACATCAGT-3’, Reverse: 5’TTGTTTTCCCCCAAATGGTA-3’. All samples were analyzed in triplicate and gene
expression normalized to Hprt1. PCR settings were as follows: 50 °C for 2 min, 95 °C for
10 min, followed by 40 cycles of 95 °C for 15 s and 60 °C for 1 min. PCR data was
analyzed using the formula 2ΔΔCT.

3. Results
3.1 Postnatal gene expression of Zfp804a throughout the entire rat brain

Author Manuscript

To assess the distribution and quantify levels of Zfp804a in the rodent brain, we performed
in situ hybridization at multiple postnatal time points. We found that Zfp804a was widely
expressed in the brain, especially in the hippocampus, cortex, thalamus, septum, and
cerebellum (Fig. 1). On a macroscopic level, the broad distribution of Zfp804a transcript
suggests that the gene potentially has broad importance in the postnatal rodent brain.
3.2 Zfp804a expression in rat frontal cortex decreases through postnatal life

Author Manuscript

We examined autoradiographically labeled sections from the frontal cortex, a region of the
brain important for executive functioning (Fig. 2). There was distinctly higher gene
expression in the lower layers (layer V, VI) of the frontal cortex compared to the upper
layers (layer I-IV). Compared across the five developmental time points assessed, Zfp804a
gene expression was 194% higher overall in the lower layers compared to the upper layers
(Fig. 2B, one-way ANOVA, F=5.44, P<0.005). Post hoc Tukey's HSD tests showed that
Zfp804a mRNA in P1 lower layers were significantly higher than measured from P21
(P<0.05), P49 (P<0.005), and P86 (P<0.005) lower layers. Furthermore, while there was a
significant difference between the P1 lower versus upper layers (Tukey's HSD, P<0.05), this
was the only developmental time point that had a statistically significant difference between
layers. Therefore, postnatal Zfp804a mRNA in frontal cortex appears to be highest at P1 and
then declines steadily throughout postnatal development.
3.3 Sub-regional changes in Zfp804a expression within the hippocampus through
postnatal neurodevelopment and neuron-specific ZFP804A expression

Author Manuscript

We next examined the hippocampus, which is a critical structure for cognitive processes, by
performing image densitometry on three distinct hippocampal subregions (Fig. 3A): area
cornu ammonis 1 (CA1), area cornu ammonis 3 (CA3), and the dentate gyrus (DG). Within
CA1, there was a peak in postnatal expression of Zfp804a transcript at P21 (Fig. 3B), which
was significantly higher than all other time points tested (one-way ANOVA with Tukey's
HSD, F=10.9, P<0.005 at least). Levels of Zfp804a mRNA in the CA3 remained stable
across postnatal life with no significant differences. Within the DG, Zfp804a transcript was
significantly higher at P21 compared to P7 (Tukey's HSD, P< 0.05), but did not differ at
other timepoints.
To examine cellular localization of Zfp804a transcript, we examined silver grains in thioninstained sections at high-magnification (Fig. 3C). Consistent with the image densitometry

Schizophr Res. Author manuscript; available in PMC 2016 October 01.

Chang et al.

Page 6

Author Manuscript

results, we found that grain density was highest at P21 in both CA1 (Fig. 3D; one-way
ANOVA with Tukey's HSD, F=13.7, P<0.00001) and DG (one-way ANOVA with Tukey's
HSD, F=12.6, P<0.0005). Furthermore, silver grains appeared to consistently cluster on
neurons while smaller cellular profiles were unlabeled (Fig. 3E). Based on morphological
criteria, these smaller cells may be glial cells, suggesting that Zfp804a expression may be
neuron-specific.
To determine whether Zfp804a is not only transcribed, but also translated in neurons, we
performed immunofluorescence staining on frozen brain sections for ZFP804A. We found
that ZFP804A expression co-localized with the neuronal marker NeuN (Fig. 4A), but did not
overlap with the astrocyte marker GFAP (Fig. 4B). These results suggest that ZFP804A is
expressed specifically in neurons.

Author Manuscript

3.4 Zfp804a expression in the thalamic medial geniculate nucleus (MGN) is significantly
decreased at P86, but mRNA levels in the thalamic reticular nucleus (TRN) are unchanged

Author Manuscript

In both coronal and sagittal brain sections of Zfp804a in situ hybridization, the thalamus
stood out as a structure with elevated expression levels (Figs. 1, 5), a finding that is
concordant with data from the P56 mouse brain (Allen Mouse Brain Atlas, http://
mouse.brain-map.org). Therefore, we decided to measure Zfp804a gene expression in two
thalamic regions that may have particular relevance to schizophrenia. The MGN, which is
involved in the processing of auditory information, had a pattern of expression that was
similar to other brain areas measured. Specifically, Zfp804a mRNA levels in MGN were
higher in early postnatal tissue compared to adult tissue (Fig. 5A). At P7 and P21, mRNA
levels were significantly higher than P86 (Tukey's HSD, P7, P<0.005; P21, P<0.05). Within
the TRN, there was a trend towards declining levels of Zfp804a transcript across age, but the
changes were not significantly different (Fig. 5B).
3.5 Zfp804a, Comt, Pde4b, and Drd2 mRNA levels in cortical neurons are modulated by
exposure to glutamate [20μM] in an NMDAR-dependent manner

Author Manuscript

To determine whether Zfp804a levels are linked to glutamate exposure, we assessed Zfp804a
expression in cortical neurons after treatment with 20μM glutamate. Untreated cells were
used as controls. We found that Zfp804a expression in cortical neurons was increased in
glutamate treated cells as compared to controls (Fig. 6A; Mann-Whitney, P < 0.05). We then
assessed Comt, Pde4b, Drd2 expression in glutamate treated neurons to determine whether
elevated levels of Zfp804a expression correlated with changes in the expression of these
genes. Similar to what was previously reported by others (Girgenti et al., 2012), we
observed an increase in Comt expression (Mann-Whitney, P < 0.05) and decrease in Drd2
expression (Mann-Whitney, P < 0.05). Pde4b expression was significantly increased by
three-fold in the presence of glutamate (Mann-Whitney, P < 0.01). Interestingly, when we
blocked NMDA receptors with the antagonist MK-801, we found no differences in
expression compared to controls for all four genes tested (Mann-Whitney, P ≥ 0.28).
Therefore, glutamate treatment of cortical neurons altered the expression levels of these
specific genes that are thought to be involved in cognitive functions in animal models and
human studies. Whether Zfp804a itself mediated the expression changes we observed in
Comt, Pde4b, and Drd2 remains to be determined.
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4. Discussion
This is the first neurodevelopmental and neurotransmitter-modulated expression data
available on Zfp804a in the rat brain. We have shown that expression of Zfp804a is highest
postnatally within the frontal cortex at P1, particularly in the lower cortical layers. Levels of
Zfp804a expression vary across hippocampal subregions, with peak expression in CA1 and
DG at age P21. In cultured primary cortical neurons, Zfp804a expression increased
significantly following exposure to glutamate in an NMDA-dependent manner. Finally,
cultured cortical neurons had increased mRNA levels of Pde4b and Comt, but decreased
Drd2 mRNA in response to glutamate exposure.

Author Manuscript

While many studies have confirmed the association of ZNF804A polymorphisms to risk for
schizophrenia and bipolar disorder in humans, the endogenous temporal and spatial
expression of this gene in the mammalian brain has not been sufficiently investigated. We
chose to maximize our spatial expression analysis by performing in situ hybridization on
both coronal and sagittal brain sections collected throughout the rat brain. We compared
expression patterns between postnatal day 1, 7, 21, 49, and 86 as these are rodent ages
approximately equivalent to the human third trimester, day of birth, childhood, adolescence,
and adulthood, respectively (Rash and Grove, 2006). Our findings provide a potentially
important characterization of when and where this gene is expressed in the brain, which is
critically important for understanding its specific role in gene regulation and neural
development.

Author Manuscript

Functional imaging studies have demonstrated that individuals with the rs1344706 SNP
have altered functional connectivity in the prefrontal cortex and hippocampus (Esslinger et
al., 2009; Rasetti et al., 2011), however, the molecular basis for this association remains
unknown. Our qPCR results (Fig. 6) suggest that glutamate exposure alone can affect
Zfp804a gene expression. This finding, coupled with the neuron-specific expression of
ZFP804A in the frontal cortex and hippocampus (Fig. 4), indicates that this gene may be
involved in the development of this intermediate phenotype.

Author Manuscript

Structural abnormalities in the frontal lobe, particularly within the prefrontal cortex, have
been a consistent observation in patients with schizophrenia (Benes et al., 1991; Goldman et
al., 1997) and may underlie cognitive deficits (Guo et al., 2014; Nakamura et al., 2008). Our
in situ hybridization results in the frontal cortex (Fig. 2) show a striking difference in
Zfp804a mRNA expression between the lower and upper cortical layers. The increased
levels of Zfp804a in the lower layers suggest that Zfp804a could be involved in neurogenesis
or neuronal migration (Hill et al., 2012) that is crucial to create the different types of
neurons and correctly position the cortical neurons that are necessary for healthy functioning
cortical structure (Stansberg et al., 2007). For example, Zfp804a transcripts may be
necessary as a protein- or RNA-binding entity (Gamsjaeger et al., 2007) for proper neuronal
migration during cortical development in the rat. This is one potential mechanism through
which ZNF804A may be involved in schizophrenia pathophysiology.
In healthy adults, ZNF804A is widely expressed in neurons from multiple regions, including
the hippocampus (Bernstein et al., 2014), but the expression patterns of this gene in
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schizophrenia are not well known. The rs1344706 risk allele is associated with allelic
expression imbalance of ZNF804A in adult dorsalateral prefrontal cortex samples (Guella et
al., 2014) and there are variable cis-effects across different areas of the adult brain,
particularly in the hippocampus (Buonocore et al., 2010). It would be interesting to
investigate whether rs1344706 carriers have altered ZNF804A expression selectively in the
CA1 region of the hippocampus during adolescence, as our results suggest that there is a
transient upregulation of Zfp804a at this neurodevelopmental stage. If there was
dysregulation of Zfp804a in this region, at this stage, then it could potentially contribute to
cognition impairment in individuals with schizophrenia (Walters et al., 2010). rs1344706
risk allele carriers have been shown to have larger hippocampal volumes than non-carriers
(Donohoe et al., 2011), suggesting a specific effect on hippocampal structure. We do not
know whether Zfp804a brain expression in the rat correlates with any volumetric or
behavioral changes.

Author Manuscript

There are several limitations to this work. The findings are primarily descriptive in nature
and we do not show how Zfp804a acts to either regulate developmental or neuronal
processes. Furthermore, we did not examine prenatal expression in this study, which could
reveal more relevant information on potential neural migration effects of the gene. In
humans, ZNF804A expression is highest prenatally, peaking right before birth (Tao et al.,
2014). Also, while we have demonstrated an effect of glutamate exposure on Zfp804a
expression in cultured neurons, we have not illuminated the molecular mechanism for these
changes outside of a potential NMDAR involvement. Lastly, we only studied male rats in
this study and there are known differences related to sex in schizophrenia, with males having
a consistently earlier onset than females (Seeman, 1982).

Author Manuscript

Our study provides insight into where one of the most widely confirmed schizophrenia risk
genes is expressed at the subregional level throughout the rat brain across postnatal
neurodevelopment. While we are not examining tissue from a rat model of schizophrenia in
this study, it is important to know the baseline levels of gene expression in these brain
regions across postnatal life for future experimental work. Given the neuroanatomical,
cognitive, and biological (Hill and Bray, 2012; Hill et al., 2012) influences of ZNF804A
rs1344706 in humans, it is important to initially investigate potential molecular mechanisms
and functions of this gene in a mammalian animal model. Our findings represent an
important step towards comprehending the association between ZNF804A and risk for
schizophrenia, bipolar disorder, and psychosis.
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Fig. 1.

Zfp804a mRNA is widely expressed throughout the rat brain at multiple postnatal time
points. Example in situ hybridization autoradiographic images are shown at five different
postnatal days (P) 1, 7, 21, 49, and 86. Panels show representative images of sagittal (A) and
coronal (B) and sections from the rat brain. (C) Representative images from P86 brains are
shown for non-specific hybridization, sense oligonucleotide, and scrambled oligonucleotide.
Scale bars: 4.0 mm.
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Fig. 2.

Zfp804a mRNA decreases in frontal cortex during postnatal life. (A) Representative
autoradiographic images of sagittal and coronal sections through the rat frontal cortex. Note
the dramatic difference in transcript levels between the lower and upper layers of frontal
cortex. (B) Image densitometry measures of the lower and upper layers of cortex show a
pattern of decreasing Zfp804a mRNA levels across postnatal life with P1 being significantly
elevated over other time points (Tukey's HSD, P<0.05). Asterisks indicate significant
differences: *p<0.05, **, p<0.005. Scale bars: 3.0 mm.
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Fig. 3.

Postnatal expression of Zfp804a mRNA varies in hippocampal areas across postnatal life.
(A) Representative images of coronal sections showing the hippocampus at different
postnatal days. (B) Top, Zfp804a gene expression within area CA1 peaks at P21, which is
significantly higher than other time points (Tukey's HSD, P<0.005). Middle, gene
expression is fairly low and stable throughout postnatal life in area CA3. Bottom, within the
DG, Zfp804a gene expression is significantly lower at P7 compared to P21 (Tukey's HSD,
P<0.05), but does not differ from other time points. (C) Representative examples of total
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and non-specific silver grain labeling within CA1. Dark silver grains show cellular
localization of Zfp804a mRNA within thionin-stained hippocampal neurons. Insets show
magnified view of labeled neurons. (D) Silver grain density for CA1 and DG confirmed the
pattern of elevated mRNA at P21 in both hippocampal regions. (Tukey's HSD, * P<0.001,
** P<0.0005) (E) A subset of smaller, thionin-positive cells that are morphologically
consistent with glial cells, show a marked absence of silver grain labeling (red arrows) in all
three hipppocampal regions. All scale bars: 10 μm.
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Fig. 4. Immunofluorescence of ZFP804A in neurons

Expression of ZFP804A in frontal cortex and hippocampal neurons. (A) Representative
immunofluorescence images show ZFP804A expression in neurons labeled with NeuN
antibody in the frontal cortex and DG of hippocampus of P21 rats. (B) ZFP804A expression
was not observed in GFAP-positive astrocytes. Scale bars: 50 μm.
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Fig. 5.

Zfp804a mRNA in MGN and TRN of thalamus. (A) Top, representative images of sagittal
sections through the MGN. Bottom, image densitometry measures within the MGN through
postnatal life show that Zfp804a expression in P86 adult rat is significantly lower than
earlier P7 and P21 ages (Tukey's HSD, P<0.05). (B) Top, representative images of sagittal
sections through the TRN. Bottom, image densitometry measures within the TRN show no
significant changes across postnatal life. Scale bars: 4.0 mm.
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Fig. 6.

Glutamate exposure upregulates Zfp804a, Pde4b, and Comt expression but decreases levels
of Drd2 expression. Plots show quantitative PCR results performed on cultures of rat
primary cortical neurons collected at embryonic day 19. All results normalized to the
reference gene Hprt1. (A) Cortical neurons exposed to glutamate [20μM] show increased
Zfp804a expression. The NMDA receptor antagonist MK-801 blocked this increase.
Glutamate exposure led to a four-fold increase in the expression of Pde4b (B) and a two-fold
increase in Comt (C) levels in cortical neurons (Student's t-test, . Both increases were
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blocked by MK-801. (D) Levels of Drd2 were significantly decreased by glutamate
exposure, but not in the presence of MK-801. Mean and SEM of three experiments is
shown; Mann-Whitney, *P<0.05, **, P<0.01.
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